7 results found.

Keratoconus Clinical Trial using Cyclosporins

Narayana Nethralaya - Recruiting 10 years to 80 years.
- Identification of Disease Progression Specific Biomarkers and Their Pharmacologic Modulation for Keratoconus..
Cyclosporins

Keratoconus, or Corneal Ectasia Clinical Trial using KXL System (15 mW/cm2); KXL System (30 mW/cm2); KXL System (45 mW/cm2); riboflavin ophthalmic solution

ACOS - Recruiting 12 years or older.
- A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery.
KXL System (15 mW/cm2); KXL System (30 mW/cm2); KXL System (45 mW/cm2); riboflavin ophthalmic solution

Keratoconus Clinical Trial using riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system; placebo: 0.0% riboflavin opthalmic solution with the KXL system

Avedro, Inc. - Recruiting 12 years or older.
- A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus.
riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system; placebo: 0.0% riboflavin opthalmic solution with the KXL system

Keratoconus, or Ectasia Clinical Trial using UVA Light with irradiance exposure of 9 mW/cm2; Riboflavin 0.1% ophthalmic solution; UVA Light with irradiance exposure of 18 mW/cm2

Columbia University - Recruiting 18 years or older.
- Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross- Linking at Higher Irradiances in Patients With Keratoconus or Ectasia.
UVA Light with irradiance exposure of 9 mW/cm2; Riboflavin 0.1% ophthalmic solution; UVA Light with irradiance exposure of 18 mW/cm2

Keratoconus, Ectasia, or Degeneration Clinical Trial

Cxlusa - Recruiting 8 years or older.
- Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas.

Progressive Keratoconus Clinical Trial using Iontophoretic CXL; Standard CXL

University Hospital, Toulouse - Recruiting 18 years or older.
- Non-inferiority Trial of Iontophoretic Corneal Collagen Crosslinking (CXL) Compared to Standard Corneal Collagen Crosslinking in Progressive Keratoconus..
Iontophoretic CXL; Standard CXL

Keratoconus Clinical Trial using Intacs intracorneal ring insertion for the treatment of keratoconus

Singapore National Eye Centre - Recruiting 21 years or older.
- Intacs for Keratoconus.
Intacs intracorneal ring insertion for the treatment of keratoconus